List of works - François-Clément Bidard

A "class action" against the microenvironment: do cancer cells cooperate in metastasis?

scientific article published on March 2008

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1).

scientific article published on 18 February 2016

A single droplet digital PCR for ESR1 activating mutations detection in plasma

scientific article published on 10 February 2020

A three dimensional thermoplastic microfluidic chip for robust cell capture and high resolution imaging

scientific article

Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial

scientific article published on 14 November 2019

Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model

scientific article published on 05 September 2014

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

scientific article

Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study.

scientific article published on 28 March 2016

Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy

scientific article published on 18 December 2015

Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights

scientific article published on 23 February 2015

Breast cancer screening: On our way to the future

scientific article

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

scientific article published on 01 November 2018

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.

scientific article published on 09 July 2014

Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer.

scientific article published on 26 June 2018

Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer.

scientific article

Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial

scientific article published on 28 May 2019

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

scientific article published on 12 April 2018

Circulating Tumor Cells in Early Breast Cancer

scientific article published on 27 April 2019

Circulating Tumor Cells, a Tremendous Prognostic Factor in Inflammatory Breast Cancer

scientific article published on 07 September 2015

Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

scientific article published on 23 October 2014

Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types

scientific article

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study

scientific article

Circulating tumor DNA detection in hepatocellular carcinoma

scientific article published on 01 May 2018

Circulating tumor cell count and thrombosis in metastatic breast cancer.

scientific article published on 5 August 2017

Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients

scientific article published on 27 April 2011

Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: The observational step of the CirCe01 phase III trial

scientific article published on 17 February 2015

Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial.

scientific article

Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?

scientific article published on 29 January 2017

Circulating tumor cells in breast cancer

scientific article

Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial

scientific article published on 14 May 2013

Circulating tumor cells: clinical validity and utility

scientific article published on 25 February 2017

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizuma

scientific article published in January 2017

Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial

scientific article published on 30 November 2018

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

scientific article

Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer

scientific article published on 22 January 2016

Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy

scientific article published on 01 October 2018

Clinical utility of circulating tumor cells in metastatic breast cancer.

scientific article

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

scientific article

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.

scientific article published on 16 March 2010

Contemporary issues and the potential uses of capecitabine in metastatic breast cancer

scientific article published on 24 July 2009

Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy

scientific article published on 7 July 2016

Diffusion-weighted MRI for uveal melanoma liver metastasis detection

scientific article published on 26 February 2015

Disseminated and circulating tumor cells in gastrointestinal oncology

scientific article published on 01 May 2012

Disseminated intravascular coagulation in solid tumours

scientific article published on 01 June 2014

Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer

scientific article published on 25 June 2009

Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse

scientific article published on 01 June 2008

Disseminated tumor cells predict efficacy of regional nodal irradiation in early stage breast cancer

scientific article published on 04 October 2018

Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).

scientific article published on 25 August 2017

ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas

scientific article published on 02 September 2016

ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics

scientific article published on 13 September 2019

ESR1 Mutation Detection and Dynamics in Meningeal Carcinomatosis in Breast Cancer

scientific article published on 19 December 2019

ESR1 mutations: a new biomarker in breast cancer

scientific article published on 19 June 2019

Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer

scientific article published on 05 December 2019

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study.

scientific article published on 19 January 2009

Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery

scientific article

Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing

scientific article published on 31 October 2013

Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients.

scientific article published on 22 January 2013

FISH in chips: turning microfluidic fluorescence in situ hybridization into a quantitative and clinically reliable molecular diagnosis tool

scientific article published in February 2015

FISH-in-CHIPS: A Microfluidic Platform for Molecular Typing of Cancer Cells.

scientific article published in January 2017

First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational Study.

scientific article published in March 2017

Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases

scientific article published on 28 March 2017

Going with the flow: from circulating tumor cells to DNA.

scientific article published in October 2013

HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report.

scientific article

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

scientific article published on 03 June 2011

High purity microfluidic sorting and analysis of circulating tumor cells: towards routine mutation detection.

scientific article

Impact of circulating tumor DNA early detection and serial monitoring in the management of stage I to III colorectal cancer ⬇️

scientific article published on 01 December 2019

Internet to boost patient accrual in oncology trials? A multiinstitutional AERIO study

scientific article published on 19 January 2011

Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients

scientific article published on 21 March 2019

Meningeal carcinomatosis in HER2-overexpressing breast cancers.

scientific article

Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays

scientific article

Microfluidic: an innovative tool for efficient cell sorting

scientific article published on 11 July 2012

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

scientific article published on 28 February 2012

Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification

scientific article

Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors.

scientific article published on 14 May 2018

Pathological response and circulating tumor cell count identifies treated HER2+ inflammatory breast cancer patients with excellent prognosis: BEVERLY-2 survival data

scientific article published on 23 December 2014

Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

scientific article

Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma

scientific article published on 24 February 2016

Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study.

scientific article

Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance

scientific article

Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells

scientific article published on 10 January 2008

Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma

scientific article published on 27 July 2018

Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma.

scientific article published on 29 May 2012

Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer

scientific article published on 7 May 2015

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

scientific article published on 25 September 2018

Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa

scientific article

T790M EGFR Mutation Detection in Cerebrospinal Fluid and Response to Osimertinib in a Lung Cancer Patient with Meningeal Carcinomatosis

scientific article published on 01 September 2017

The Genomic Landscape of Male Breast Cancers

scientific article published on 9 March 2016

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

scientific article published on 19 December 2018

Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse

scientific article published on 07 November 2008

Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study.

scientific article published on 9 May 2013

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations

scientific article published on 10 August 2019

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions

scientific article published on 10 August 2019

Translating metastasis-related biomarkers to the clinic--progress and pitfalls

scientific article published on 05 February 2013

Trends in cancer-targeted antibody-drug conjugates.

scientific article

Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma

scientific article published on 13 May 2020

Validation of the Institut Curie simplified prognostic score for breast cancer meningeal carcinomatosis

scientific article published on 20 December 2010

Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma.

scientific article

[Circulating tumor cells and breast cancer: detection techniques and clinical results]

scientific article published on 01 January 2009

[Circulating tumour DNA: Current detection methods, use in radiotherapy and future development]

scientific article published on 18 August 2018

[Erratum to: "Breast cancer screening: On our way to the future" [Bull. Cancer 103 (2016) 753-763]]

scientific article published on 28 October 2016

[Survival of breast cancers patients with meningeal carcinoma]

scientific article published on 01 April 2011

[The metastatic process: history, models and recent advances]

scientific article published on 27 January 2012

List of works by François-Clément Bidard

A "class action" against the microenvironment: do cancer cells cooperate in metastasis?

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1).

A single droplet digital PCR for ESR1 activating mutations detection in plasma

A three dimensional thermoplastic microfluidic chip for robust cell capture and high resolution imaging

Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial

Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study.

Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy

Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights

Breast cancer screening: On our way to the future

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.

Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer.

Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer.

Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

Circulating Tumor Cells in Early Breast Cancer

Circulating Tumor Cells, a Tremendous Prognostic Factor in Inflammatory Breast Cancer

Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study

Circulating tumor DNA detection in hepatocellular carcinoma

Circulating tumor cell count and thrombosis in metastatic breast cancer.

Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients

Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: The observational step of the CirCe01 phase III trial

Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial.

Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?

Circulating tumor cells in breast cancer

Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial

Circulating tumor cells: clinical validity and utility

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizuma

Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer

Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy

Clinical utility of circulating tumor cells in metastatic breast cancer.

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.

Contemporary issues and the potential uses of capecitabine in metastatic breast cancer

Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy

Diffusion-weighted MRI for uveal melanoma liver metastasis detection

Disseminated and circulating tumor cells in gastrointestinal oncology

Disseminated intravascular coagulation in solid tumours

Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer

Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse

Disseminated tumor cells predict efficacy of regional nodal irradiation in early stage breast cancer

Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).

ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas

ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics

ESR1 Mutation Detection and Dynamics in Meningeal Carcinomatosis in Breast Cancer

ESR1 mutations: a new biomarker in breast cancer

Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study.

Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery

Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing

Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients.

FISH in chips: turning microfluidic fluorescence in situ hybridization into a quantitative and clinically reliable molecular diagnosis tool

FISH-in-CHIPS: A Microfluidic Platform for Molecular Typing of Cancer Cells.

First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational Study.

Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases

Going with the flow: from circulating tumor cells to DNA.

HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report.

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

High purity microfluidic sorting and analysis of circulating tumor cells: towards routine mutation detection.

Impact of circulating tumor DNA early detection and serial monitoring in the management of stage I to III colorectal cancer ⬇️

Internet to boost patient accrual in oncology trials? A multiinstitutional AERIO study

Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients

Meningeal carcinomatosis in HER2-overexpressing breast cancers.

Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays

Microfluidic: an innovative tool for efficient cell sorting

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification

Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors.

Pathological response and circulating tumor cell count identifies treated HER2+ inflammatory breast cancer patients with excellent prognosis: BEVERLY-2 survival data

Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma

Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study.

Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance